Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
2.535,75 INR | +4,52% | +4,29% | +27,91% |
12/09 | Durex spinge i preservativi in India per le donne e i consumatori rurali | RE |
13/08 | Mankind Pharma Limited riconferma S. R. Batliboi & Co. LLP come revisore legale congiunto | CI |
Aggiungi a un elenco 0 selezionato | Fatturato ($) (Y-1) | Margine netto (Y-1) | Margine Operativo (Y-1) | ROE (Y-1) | ROA (Y-1) | Leva (indebitamento/EBITDA) (Y-1) | |
---|---|---|---|---|---|---|---|
1,24 Mrd | +18.51% | +20.68% | +22.77% | +17.65% | -1.29x | ||
34,12 Mrd | +15.36% | +20.68% | +48.93% | +9.23% | 2.6x | ||
34,7 Mrd | +36.03% | +44.16% | +88.07% | +30.12% | -0.03x | ||
85,16 Mrd | +41.28% | +32.25% | +34.91% | +14.32% | 0.21x | ||
54,32 Mrd | +8.95% | +45.64% | +143.18% | +14.46% | 1.82x | ||
60,12 Mrd | +0.61% | +10.33% | +9.18% | +3.56% | 2.77x | ||
69,28 Mrd | +19.58% | +32.77% | +45.73% | +16.71% | 0.85x | ||
45,81 Mrd | +13.01% | +31.73% | +29.77% | +11.48% | 1.66x | ||
45,44 Mrd | +32.69% | +36.03% | +25.37% | +12.37% | 0.67x | ||
28,19 Mrd | +23.83% | +47.53% | +202.85% | +12.37% | 3.07x | ||
58,5 Mrd | +3.62% | +15.90% | +11.37% | +4.96% | 3.8x | ||
47,97 Mrd | +12.54% | +29.42% | +13.65% | +4.27% | 0.55x | ||
27,12 Mrd | +20.89% | +38.66% | +38.46% | +13.49% | 1.34x | ||
45,01 Mrd | +17.83% | +37.30% | +51.57% | +8.36% | 1.55x | ||
40,25 Mrd | +16.25% | +28.97% | +52.48% | +10.55% | 1.29x | ||
7,79 Mrd | +29.29% | +39.52% | +21.30% | +23.34% | -1.57x | ||
11,22 Mrd | +12.53% | +13.21% | +12.80% | +7.95% | -2.01x | ||
29,87 Mrd | +3.38% | +5.02% | +2.10% | +0.36% | 4.66x | ||
15 Mrd | +9.28% | +22.55% | +6.37% | +3.05% | 3.01x | ||
Media | 39 Mrd | +17,66% | +29,07% | +45,31% | +11,50% | 1,31x | |
Media ponderata per Capi. | 46,09 Mrd | +20,26% | +30,93% | +56,94% | +13,43% | 1,47x |
- Borsa valori
- Azioni
- Azione MANKIND
- Settore Mankind Pharma Limited
- Confronti finanziari
MarketScreener is also available in this country: United States.
Switch edition